{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:38:18Z","timestamp":1789000698090,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd000332.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"reference-count":133,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000332.pub3","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T06:17:28Z","timestamp":1361600248000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[{"name":"Iberoamerican Cochrane Network; Valencia Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis H","family":"Agreda-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Hospital \"Dr. Adolfo Prince Lara\"; Medicina Interna; Av. Salom Pto. Cabello Edo. Carabobo Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 - Edifici Casa de Convalesc\u00e8ncia Barcelona Catalunya Spain 08041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00270309","article-title":"Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis","volume":"17","author":"Nordstr\u00f6m","year":"1997","journal-title":"Rheumatology International"},{"issue":"5-6","key":"10.1002\/14651858.CD000332.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002960050085","article-title":"Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures","volume":"18","author":"Peeters","year":"1999","journal-title":"Rheumatology International"},{"issue":"10","key":"10.1002\/14651858.CD000332.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/ard.55.10.739","article-title":"Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomized placebo controlled double blind 52 weeks clinical trial","volume":"55","author":"Peeters","year":"1996","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-9343(90)90294-N","article-title":"Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis","volume":"89","author":"Pincus","year":"1990","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000332.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00277-004-0950-z","article-title":"Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin","volume":"84","author":"Arndt","year":"2005","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0006|cit6","first-page":"295-303; discus","article-title":"Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin","volume":"88","author":"Birgegard","year":"1991","journal-title":"Contributions to Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0007|cit7","first-page":"731","article-title":"[Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hormones in females with rheumatoid arthritis]","volume":"114","author":"Dyjas","year":"2005","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Fantini F Gattinara M Gerloni V Bergomi P Cirla E Severe anemia associated with active systemic-onset juvenile rheumatoid arthritis successfully treated with recombinant human erythropoietin: a pilot study Arthritis and Rheumatism 1992 724 6","DOI":"10.1002\/art.1780350622"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-2143(97)90037-8","article-title":"The erythropoietic response to erythropoietin in patients with rheumatoid arthritis","volume":"130","author":"Goodnough","year":"1997","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"issue":"11","key":"10.1002\/14651858.CD000332.pub3-BIB0010|cit10","first-page":"2430","article-title":"Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis","volume":"28","author":"Kaltwasser","year":"2001","journal-title":"The Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2169\/internalmedicine.33.193","article-title":"Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis","volume":"33","author":"Kato","year":"1994","journal-title":"Internal Medicine (Tokyo, Japan)"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/10.supp2.10","article-title":"Erythropoietin and the anaemia of chronic disease","volume":"10 Suppl 2","author":"Krantz","year":"1995","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3928\/0147-7447-20010101-17","article-title":"Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty","volume":"24","author":"Matsuda","year":"2001","journal-title":"Orthopedics"},{"issue":"5","key":"10.1002\/14651858.CD000332.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/anr.1780320519","article-title":"Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies","volume":"32","author":"Means","year":"1989","journal-title":"Arthritis and Rheumatism"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD000332.pub3-BIB0015|cit15","first-page":"18-20; discussi","article-title":"Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia","volume":"33","author":"Mercuriali","year":"1996","journal-title":"Seminars in Hematology"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1423-0410.1997.7220093.x","article-title":"Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery","volume":"72","author":"Mercuriali","year":"1997","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0017|cit17","unstructured":"Mercuriali F Gualtieri G Biffi E Inghilleri G Colotti M Vinci A Intravenous vs subcutaneous erythropoietin for autologous blood donation in anemic rheumatoid arthritis patients Transfusion Supplement 1994"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0018|cit18","unstructured":"Mercuriali F Gualtieri G Inghilleri G Biffi E Vinci A Colotti M Erythropoietin and autologous blood donation in surgical rheumatoid arthritis patients with anemia Transfusion Abstract Florida 1993"},{"issue":"6965","key":"10.1002\/14651858.CD000332.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.309.6965.1337","article-title":"Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis","volume":"309","author":"Murphy","year":"1994","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/03009749309099269","article-title":"Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation","volume":"22","author":"Pettersson","year":"1993","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/17453679408993710","article-title":"Autologous blood transfusion with recombinant erythropoietin treatment. 22 arthroplasties for rheumatoid arthritis","volume":"65","author":"Saikawa","year":"1994","journal-title":"Acta Orthopaedica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD000332.pub3-BIB0022|cit22","first-page":"1168","article-title":"Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease","volume":"18","author":"Salvarani","year":"1991","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0023|cit23","unstructured":"Swaak AJ Nieuwenhuizen C Vreugdenhil G Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD) Clinical and Experimental Rheumatology 1994 577"},{"issue":"7","key":"10.1002\/14651858.CD000332.pub3-BIB0024|cit24","first-page":"885","article-title":"Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis","volume":"17","author":"Takashina","year":"1990","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Tauchi T Ohyashiki JH Fujieda H Lin KY Ohyashiki K Toyama K Correction of anaemia in rheumatoid arthritis by recombinant human erythropoietin British Journal of Rheumatology 1990 235 6","DOI":"10.1093\/rheumatology\/29.3.235-a"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02030236","article-title":"The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis","volume":"9","author":"Vreugdenhil","year":"1990","journal-title":"Clinical Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD000332.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01836071","article-title":"Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis","volume":"65","author":"Vreugdenhil","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000243794","article-title":"Anemia of chronic disease (anemia of inflammation)","volume":"122","author":"Agarwal","year":"2009","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5144\/0256-4947.51774","article-title":"Extra-articular manifestations of rheumatoid arthritis: a hospital-based study","volume":"29","author":"Al-Ghamdi","year":"2009","journal-title":"Annals of Saud\u00ed Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Alten R Pohl C Choy EH Christensen R Furst DE Hewlett SE Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group The Journal of Rheumatology 2011 1745 50","DOI":"10.3899\/jrheum.110400"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","article-title":"Iron homeostasis","volume":"69","author":"Andrews","year":"2007","journal-title":"Annual Review of Physiology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2007-12-077388","article-title":"Forging a field: the golden age of iron biology","volume":"112","author":"Andrews","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2141.1987.tb01344.x","article-title":"Blunted erythropoietin response to anaemia in rheumatoid arthritis","volume":"66","author":"Baer","year":"1987","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0036|cit36","unstructured":"Bartlett SJ Hewlett S Bingham CO 3rd Woodworth TG Alten R Pohl C Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus Annals of the Rheumatic Diseases"},{"issue":"15","key":"10.1002\/14651858.CD000332.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Basch","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Bingham CO 3rd Alten R Bartlett SJ Bykerk VP Brooks PM Choy E Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop The Journal of Rheumatology 2011 1751 8","DOI":"10.3899\/jrheum.110401"},{"issue":"3","key":"10.1002\/14651858.CD000332.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003785","article-title":"Infliximab for the treatment of rheumatoid arthritis","author":"Blumenauer","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000332.pub3-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004525","article-title":"Etanercept for the treatment of rheumatoid arthritis","author":"Blumenauer","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cyto.a.20512","article-title":"Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice","volume":"73","author":"Capocasale","year":"2008","journal-title":"Cytometry A"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0043|cit43","first-page":"351","article-title":"The anemia of chronic disorders","volume":"3","author":"Cartwright","year":"1966","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1358\/dot.2003.39.7.799441","article-title":"Darbepoetin alfa: a novel erythropoiesis-stimulating protein","volume":"39","author":"Cases","year":"2003","journal-title":"Drugs of Today (Barc)"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1042\/BST0331129","article-title":"Novel tissue remodelling roles for human recombinant erythropoietin","volume":"33 (Pt 5)","author":"Coussons","year":"2005","journal-title":"Biochemical Society Transactions"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0047|cit47","first-page":"11","article-title":"Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis","volume":"65 (Suppl 1)","author":"Cronstein","year":"2007","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/kep329","article-title":"Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor","volume":"49","author":"Dayer","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.48.1578","article-title":"Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis","volume":"48","author":"Demirag","year":"2009","journal-title":"Internal Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0050|cit50","unstructured":"Food Drug Administration EPOGEN (epoetin alfa) solution http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=9169 [Accessed January 29, 2010]"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0051|cit51","unstructured":"Food Drug Administration Erythropoiesis Stimulating Agents: Aranesp (darbepoetin alfa), Epogen (epoetin alfa), and Procrit (epoetin alfa) http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm110251.htm"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","article-title":"Interleukin-6 as a key player in systemic inflammation and joint destruction","volume":"8","author":"Fonseca","year":"2009","journal-title":"Autoimmunity Reviews"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0053|cit53","first-page":"560","article-title":"Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry","volume":"27","author":"Furst","year":"2009","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0054|cit54","unstructured":"Gabriel SE Normand SL Getting the methods right - the foundation of patient-centered outcomes research The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.seminhematol.2009.06.001","article-title":"Iron sequestration and anemia of inflammation","volume":"46","author":"Ganz","year":"2009","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.60.050307.110718","article-title":"Erythropoietin in cancer patients","volume":"60","author":"Glaspy","year":"2009","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0057|cit57","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0720-048X(98)00038-2","article-title":"The clinical features of rheumatoid arthritis","volume":"27 (Suppl 1)","author":"Grassi","year":"1998","journal-title":"European Journal of Radiology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.51.6.747","article-title":"Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin","volume":"51","author":"Gudbj\u00f6rnsson","year":"1992","journal-title":"Annals of Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD000332.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD000332.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD000332.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD000332.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD000332.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0068|cit68","first-page":"2177","article-title":"Association of anemia and physical disability among patients with rheumatoid arthritis","volume":"34","author":"Han","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/djp387","article-title":"Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer","volume":"101","author":"Hershman","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0071|cit71","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.5 [updated September 29th, 2009]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/art.1780311016","article-title":"Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia","volume":"31","author":"Hochberg","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1185\/030079908X261177","article-title":"The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006","volume":"24","author":"Hochberg","year":"2008","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Hopewell S Clarke M Higgins JPT (editors) Core reporting of outcomes in effectiveness trials Cochrane Methods. Cochrane Database of Systematic Reviews 2010 1 29","DOI":"10.1002\/14651858.CD201001"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2165\/00003495-200161140-00007","article-title":"Darbepoetin alfa","volume":"61","author":"Ibbotson","year":"2001","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"417\u201334","DOI":"10.1146\/annurev.pathol.4.110807.092254","article-title":"The immunopathogenesis of rheumatoid arthritis","volume":"4","author":"Imboden","year":"2009","journal-title":"Annual Review of Pathology"},{"issue":"10","key":"10.1002\/14651858.CD000332.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD000332.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"The art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0079|cit79","first-page":"17","article-title":"Decreased expression of integrins by hematopoietic cells in patients with rheumatoid arthritis and anemia: relationship with bone marrow cytokine levels","volume":"18","author":"Jaworski","year":"2008","journal-title":"Journal of Investigational Allergology & Clinical Immunology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/00313020802436840","article-title":"Serum prohepcidin concentrations in rheumatoid arthritis","volume":"41","author":"Jayaranee","year":"2009","journal-title":"Pathology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomized controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0082|cit82","first-page":"1174","article-title":"Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis","volume":"34","author":"Kirwan","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine--40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annual Review of Immunology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/stem.5530080717","article-title":"Erythropoietin: receptors and clinical use in rheumatoid arthritis","volume":"8 (Suppl 1)","author":"Krantz","year":"1990","journal-title":"International Journal of Cell Cloning"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.pathol.4.110807.092205","article-title":"Regulation of hepcidin and iron-overload disease","volume":"4","author":"Lee","year":"2009","journal-title":"Annual Review of Pathology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2005.01528.x","article-title":"Hyporesponsiveness to erythropoietic therapy due to chronic inflammation","volume":"35 (Suppl 3)","author":"Macdougall","year":"2005","journal-title":"European Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2010.05.017","article-title":"Rheumatoid anemia","volume":"78","author":"Masson","year":"2011","journal-title":"Joint, Bone, Spine"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007277.pub2","article-title":"Abatacept for rheumatoid arthritis","author":"Maxwell","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23","key":"10.1002\/14651858.CD000332.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/stem.5530130105","article-title":"Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia","volume":"13","author":"Means","year":"1995","journal-title":"Stem Cells"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005121.pub3","article-title":"Anakinra for rheumatoid arthritis","author":"Mertens","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","article-title":"Comorbidities in rheumatoid arthritis","volume":"21","author":"Michaud","year":"2007","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2008.08.003","article-title":"Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms","volume":"39","author":"Moreland","year":"2009","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3748\/wjg.15.4617","article-title":"An update on iron physiology","volume":"15","author":"Mu\u00f1oz","year":"2009","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD000332.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005113.pub2","article-title":"Adalimumab for treating rheumatoid arthritis","author":"Navarro-Sarabia","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2003","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0101|cit101","first-page":"380","article-title":"Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality","volume":"35","author":"Nikolaisen","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/art.1780330403","article-title":"Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group","volume":"33","author":"Paulus","year":"1990","journal-title":"Arthritis and rheumatism"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0104|cit104","unstructured":"Patient-Centered Outcomes Research Institute (PCORI) Preliminary draft methodology report: \u201cOur questions, our decisions: Standards for patient-centered outcomes research\u201d http:\/\/www.pcori.org\/assets\/Preliminary-Draft-Methodology-Report.pdf 1 61"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/03009749309099269","article-title":"Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation","volume":"22","author":"Pettersson","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/33.6.526","article-title":"Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis","volume":"33","author":"Pettersson","year":"1994","journal-title":"British Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0107|cit107","volume-title":"A Dictionary of Epidemiology","author":"Porta","year":"2008"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.semarthrit.2008.01.006","article-title":"Role of interleukin-6 in the anemia of chronic disease","volume":"38","author":"Raj","year":"2009","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0109|cit109","unstructured":"The Nordic Cochrane Centre: The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00062752-200503000-00001","article-title":"Anemia of inflammation: the hepcidin link","volume":"12","author":"Roy","year":"2005","journal-title":"Current Opinion in Hematology"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007649.pub2","article-title":"Certolizumab pegol (CDP870) for rheumatoid arthritis in adults","author":"Ruiz Garcia","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"17","key":"10.1002\/14651858.CD000332.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Anti-hepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD000332.pub3-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007848.pub2","article-title":"Biologics for rheumatoid arthritis: an overview of Cochrane reviews","author":"Singh","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008341","article-title":"Golimumab for rheumatoid arthritis","author":"Singh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD000332.pub3-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008331.pub2","article-title":"Tocilizumab for rheumatoid arthritis","author":"Singh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000332.pub3-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008794.pub2","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.51.6.753","article-title":"Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages","volume":"51","author":"Smith","year":"1992","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMp0912328","article-title":"Erythropoiesis-stimulating agents--time for a reevaluation","volume":"362","author":"Unger","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000332.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"Putten","year":"2008","journal-title":"Nature Clinical Practice. Nephrology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2362.1992.tb01495.x","article-title":"Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis","volume":"22","author":"Vreugdenhil","year":"1992","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01836071","article-title":"Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis","volume":"65","author":"Vreugdenhil","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1054\/blre.2002.0193","article-title":"Pathogenesis and treatment of anaemia of chronic disease","volume":"16","author":"Weiss","year":"2002","journal-title":"Blood Review"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagen.2008.08.006","article-title":"Iron metabolism in the anemia of chronic disease","volume":"1790","author":"Weiss","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0128|cit128","volume-title":"Worldwide prevalence of anaemia 1993\u20132005 : WHO global database on anaemia","author":"Benoist","year":"2008"},{"issue":"Suppl 7A","key":"10.1002\/14651858.CD000332.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2003.12.012","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/cncr.11810","article-title":"Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses","volume":"98","author":"Wu","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","article-title":"Extra-articular manifestations and complications of rheumatoid arthritis","volume":"21","author":"Young","year":"2007","journal-title":"Best Practice & Reserach. Clinical Rheumatology"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0132|cit132","doi-asserted-by":"crossref","unstructured":"Zhang AS Enns CA Molecular mechanisms of normal iron homeostasis Hematology \/ the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009 207 14","DOI":"10.1182\/asheducation-2009.1.207"},{"key":"10.1002\/14651858.CD000332.pub3-BIB0133|cit133","first-page":"587","article-title":"The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis","volume":"21","author":"Zhu","year":"2000","journal-title":"Zhonghua Xueyexue Zazhi"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000332.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:32:12Z","timestamp":1725960732000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000332.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":133,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000332.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}